Aytaç Yeğin Appointed as Commercial Lead for Pfizer Turkey

Aytaç Yeğin, who joined Pfizer in 2011 as a Project Manager in the Business Development Department and has been serving as the Category Leader for Rare Diseases in Pfizer Turkey since early 2024, has been appointed as the Commercial Leader of Pfizer Turkey.

Yeğin graduated from the Electrical Engineering Department of Istanbul Technical University in 2007 and completed his MBA at Koç University in 2011. He began his career at Pfizer Turkey in 2011 as a Project Manager in the Business Development Department. Between March 2013 and 2015, he served as a Product Manager in the Hospital Category, then from March 2015 to 2017, he worked as a Product Manager and Portfolio Leader in the Neuropathic Pain field, and from 2017 to 2020, he held various roles as Marketing Manager and Marketing Director in the Established Products group. Following the spin-off of the Upjohn business unit from Pfizer, he continued as Marketing Director at Viatris from 2020 to 2023. Rejoining Pfizer Turkey in August 2023, Yeğin initially served as the Hospital & Covid Category Leader and then as the Rare Diseases Category Leader. He began his new role as the Commercial Leader of Pfizer Turkey on December 1, 2024.

Aytaç Yeğin stated regarding his new position as Commercial Leader of Pfizer Turkey: “Since the day I started working at Pfizer, known as the school of leaders, I have taken on various roles in many different areas thanks to the company's rotation culture. I am very excited about my new role as a Commercial Leader, where I will play an active role in ensuring patients have uninterrupted access to Pfizer's vaccines and treatments. I am proud to be a part of Pfizer, which operates with a patient and caregiver-focused approach and a belief that science will prevail.”